124 related articles for article (PubMed ID: 22155875)
21. Placement of double-J ureteric stent using the pull-through technique in patients with tight ureteric stenosis.
Kim BM; Park SI
Abdom Imaging; 2008; 33(2):237-40. PubMed ID: 17440767
[TBL] [Abstract][Full Text] [Related]
22. Cost analysis of prophylactic intraoperative cystoscopic ureteral stents in gynecologic surgery.
Fanning J; Fenton B; Jean GM; Chae C
J Am Osteopath Assoc; 2011 Dec; 111(12):667-9. PubMed ID: 22182952
[TBL] [Abstract][Full Text] [Related]
23. Experience with Memokath 051 ureteral stent.
Klarskov P; Nordling J; Nielsen JB
Scand J Urol Nephrol; 2005; 39(2):169-72. PubMed ID: 16019773
[TBL] [Abstract][Full Text] [Related]
24. [Use of double J ureteral stent as an alternative to prevent ureteroileal anastomosis stricture in orthotopic bladder substitution].
Echo H; Zerbib M; Saighi D; Amsellem-Ouazana D; Flam T; Debré B; Peyromaure M
Prog Urol; 2009 Feb; 19(2):127-31. PubMed ID: 19168018
[TBL] [Abstract][Full Text] [Related]
25. [Ureteral drainage with the Gibbons indwelling ureteral stent (author's transl)].
Schreiber B
Urologe A; 1979 May; 18(3):164-8. PubMed ID: 452188
[TBL] [Abstract][Full Text] [Related]
26. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
27. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.
Arguedas MR; Heudebert GH; Stinnett AA; Wilcox CM
Am J Gastroenterol; 2002 Apr; 97(4):898-904. PubMed ID: 12003425
[TBL] [Abstract][Full Text] [Related]
28. [Is effective the initial management of primary nonrefluxing megaureter with double-J stent?].
Barbancho DC; Fraile AG; Sánchez RT; Díaz ML; Fernández MM; Vázquez FL; Bramtot AA
Cir Pediatr; 2008 Jan; 21(1):32-6. PubMed ID: 18444388
[TBL] [Abstract][Full Text] [Related]
29. Metallic ureteral stents: a cost-effective method of managing benign upper tract obstruction.
López-Huertas HL; Polcari AJ; Acosta-Miranda A; Turk TM
J Endourol; 2010 Mar; 24(3):483-5. PubMed ID: 20210650
[TBL] [Abstract][Full Text] [Related]
30. Bacterial characteristics and clinical significance of ureteral double-J stents in children.
García-Aparicio L; Blázquez-Gómez E; Martin O; Krauel L; de Haro I; Rodó J
Actas Urol Esp; 2015; 39(1):53-6. PubMed ID: 24954842
[TBL] [Abstract][Full Text] [Related]
31. [Effects of preventive double-J stent placement in ureteral obstruction treatment with metal stents on animal model].
Morcillo E; Sánchez-Margallo FM; Serrano A; Fernández-Aparicio T; Pamplona M; Soria F
Arch Esp Urol; 2015 Nov; 68(9):701-9. PubMed ID: 26530867
[TBL] [Abstract][Full Text] [Related]
32. Application of resonance metallic stents for ureteral obstruction.
Wang HJ; Lee TY; Luo HL; Chen CH; Shen YC; Chuang YC; Chiang PH
BJU Int; 2011 Aug; 108(3):428-32. PubMed ID: 21062397
[TBL] [Abstract][Full Text] [Related]
33. Preliminary experience with external ureteropelvic stent: alternative to double-j stent in laparoscopic pyeloplasty in children.
Helmy T; Blanc T; Paye-Jaouen A; El-Ghoneimi A
J Urol; 2011 Mar; 185(3):1065-9. PubMed ID: 21262512
[TBL] [Abstract][Full Text] [Related]
34. [The "double J" endo-ureteral prosthesis. Experience apropos of 21 cases].
Abourachid H; Petit J; Sueur JP; Locquet P; Turblin JM
Ann Urol (Paris); 1984; 18(4):266-70. PubMed ID: 6529235
[TBL] [Abstract][Full Text] [Related]
35. Determining the proper stent length to use in children: age plus 10.
Palmer JS; Palmer LS
J Urol; 2007 Oct; 178(4 Pt 2):1566-9. PubMed ID: 17707050
[TBL] [Abstract][Full Text] [Related]
36. Application of self-expandable metal stents for ureteroileal anastomotic strictures: long-term results.
Liatsikos EN; Kagadis GC; Karnabatidis D; Katsanos K; Papathanassiou Z; Constantinides C; Perimenis P; Nikiforidis GC; Stolzenburg JU; Siablis D
J Urol; 2007 Jul; 178(1):169-73. PubMed ID: 17499298
[TBL] [Abstract][Full Text] [Related]
37. The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance.
Eaton Turner E; Jenks M; McCool R; Marshall C; Millar L; Wood H; Peel A; Craig J; Sims AJ
Appl Health Econ Health Policy; 2018 Aug; 16(4):445-464. PubMed ID: 29616460
[TBL] [Abstract][Full Text] [Related]
38. Natural course of inoperable esophageal cancer treated with metallic expandable stents: quality of life and cost-effectiveness analysis.
Xinopoulos D; Dimitroulopoulos D; Moschandrea I; Skordilis P; Bazinis A; Kontis M; Paraskevas I; Kouroumalis E; Paraskevas E
J Gastroenterol Hepatol; 2004 Dec; 19(12):1397-402. PubMed ID: 15610314
[TBL] [Abstract][Full Text] [Related]
39. Investigation of a novel degradable ureteral stent in a porcine model.
Hadaschik BA; Paterson RF; Fazli L; Clinkscales KW; Shalaby SW; Chew BH
J Urol; 2008 Sep; 180(3):1161-6. PubMed ID: 18639278
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and clinical significance of bacterial colonization of ureteral double-J stents in children.
Ben-Meir D; Golan S; Ehrlich Y; Livne PM
J Pediatr Urol; 2009 Oct; 5(5):355-8. PubMed ID: 19251483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]